| Literature DB >> 23019479 |
Marcus Frings1, Isabelle Thomé, Carsten Bolm.
Abstract
For the first time, chiral sulfoximine derivatives have been applied as asymmetric organocatalysts. In combination with a thiourea-type backbone the sulfonimidoyl moiety leads to organocatalysts showing good reactivity in the catalytic desymmetrization of a cyclic meso-anhydride and moderate enantioselectivity in the catalytic asymmetric Biginelli reaction. Straightforward synthetic routes provide the newly designed thiourea-sulfoximine catalysts in high overall yields without affecting the stereohomogeneity of the sulfur-containing core fragment.Entities:
Keywords: anhydride opening; catalytic asymmetric Biginelli reaction; organocatalysis; sulfoximines; thioureas
Year: 2012 PMID: 23019479 PMCID: PMC3458769 DOI: 10.3762/bjoc.8.164
Source DB: PubMed Journal: Beilstein J Org Chem ISSN: 1860-5397 Impact factor: 2.883
Figure 1General structure of sulfoximines 1 and one of the enantiomers of S-methyl-S-phenylsulfoximine ((S)-2) used in this study.
Figure 2Structures of chiral mono- and bifunctional (bis-)thioureas that have been used as organocatalysts.
Scheme 1Synthesis of compound (S)-3.
Scheme 2Organocatalytic desymmetrization of the cyclic anhydride 4 with (S)-3.
Scheme 3Attempted synthesis of sulfonimidoyl-substituted thiourea (R)-9.
Scheme 4Synthesis of the sulfonimidoyl-containing thioureas (S)-12 and (S)-13.
Scheme 5Syntheses of ethylene-linked sulfonimidoyl-containing thioureas (SS,SC)-18 and (RS,SC)-19.
Evaluation of the sulfonimidoyl-containing thiourea organocatalysts in the asymmetric Biginelli reaction to afford scalemic dihydropyrimidinone (S)-20.
| entry | chiral | catalyst loading (mol %)/ | time (d) | substrate concentration (mol/L)a | yield (%) | er (%)b |
| 1 | ( | 10/0.025 | 3 | 0.25 | 28 | 50:50 |
| 2 | ( | 10/0.025 | 3 | 0.25 | 32 | 50:50 |
| 3 | ( | 10/0.025 | 3 | 0.25 | 30 | 50:50 |
| 4 | ( | 10/0.025 | 3 | 0.25 | 42 | 58:42 |
| 5 | ( | 10/0.025 | 3 | 0.25 | 21 | 57:43 |
| 6 | ( | 10/0.025 | 5 | 0.25 | 89 | 58:42 |
| 7 | ( | 10/0.025 | 5 | 0.25 | 40 | 57:43 |
| 8 | ( | 20/0.05 | 5 | 0.25 | 90 | 59:41 |
| 9 | ( | 20/0.05 | 5 | 0.25 | 42 | 57:43 |
| 10 | ( | 10/0.0025 | 5 | 0.025 | 92 | 72:28 |
| 11 | ( | 1/0.0025 | 5 | 0.25 | 53 | 51:49 |
aWith respect to urea. bDetermined by HPLC analysis with a chiral stationary phase.